Answers are grounded in this paper and cite their sources.
Autoimmune hemolytic anemia (AIHA) is a rare hematologic disorder that may occur as a primary disease or develop secondary to autoimmune diseases, infections, or malignant lymphoma. In patients with malignant lymphoma, AIHA is clinically important because it has been associated with unfavorable treatment outcomes. A 75-year-old woman with a prior diagnosis of angioimmunoblastic T-cell lymphoma (AITL) presented with recurrent fever, dyspnea, and jaundice after completing six cycles of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) chemotherapy. Laboratory evaluation showed severe anemia, indirect hyperbilirubinemia, low haptoglobin, and positive direct and indirect antiglobulin (Coombs) tests, supporting a diagnosis of AIHA; a low-titer cold agglutinin was also detected. 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) demonstrated findings consistent with relapsed AITL. Although she had no meaningful early response to corticosteroid monotherapy, hemolytic parameters improved and PET/CT showed a partial metabolic response after ICE (ifosfamide, carboplatin, and etoposide) chemotherapy. After six cycles of ICE chemotherapy, her blood counts and hemolytic markers had normalized, PET/CT continued to show a partial metabolic response, and her performance status had improved substantially. This case shows that AIHA can occur concurrently with AITL relapse. Clinicians should consider AIHA when patients with lymphoma present with clinical or laboratory findings suggestive of hemolysis. In this setting, assessment of lymphoma disease activity and treatment of the underlying lymphoma may be important components of management. Further studies of the immunopathogenesis of AIHA in malignant lymphoma are needed to improve diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: